| Trial registration number
|
NCT05214196 |
Full text link
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05214196
|
First author
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Alparslan Dilsiz, Prof.
|
Contact
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
2022-01-28
|
Recruitment status
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 12, 2022, 3:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
positive sars-cov-2 rt-pcr result,
adult hospitalized patient,
the participants have the physical and psychological ability to follow the instructions in the study.
|
Exclusion criteria
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
patients intubated and supported by a mechanical respirator,
severe acute or chronic medical or psychiatric condition,
history of significant adverse effects following use of oral hygiene products such as toothpaste and mouth rinses,
active uncontrolled thyroid disease,
developmental/cognitive disability,
pregnancy,
undergoing radioactive iodine therapy.
|
Number of arms
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
3
|
Funding
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Ataturk University
|
Inclusion age min
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Turkey
|
Type of patients
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
75
|
primary outcome
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
RT-PCR analysis
|
Notes
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Phase 4
|
Arms
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 614, "treatment_name": "Hypochlorous acid", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1015, "treatment_name": "Povidone-iodine", "treatment_type": "Mouthwash", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|